Pilocarpine Hydrochloride (Allergan)

盐酸毛果芸香碱 (艾尔建)

Report date: 2026/04/25 20:00:23

Base Information

Drug NamePilocarpine Hydrochloride (Allergan)
Drug Alias Name毛果芸香碱1.25%pilocarpine HCI ophthalmic solution匹鲁卡品VuityAGN-190584
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor agonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsPseudophakiaChoroidal NeovascularizationMacular Degeneration +[6] 
Global Approved IndicationsPresbyopia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/10/28
Country/TerritoryUnited StatesPhilippinesAustralia +[4] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesMaastricht University Medical CenterShahid Beheshti University Of Medical SciencesAbbvie Inc +[4] 
Inactive CompaniesAllergan Plc
Active IndicationsPseudophakiaPresbyopiaMyopia +[4] 
Inactive IndicationsChoroidal NeovascularizationMacular Degeneration

Other Information

ATC CodeN/A
Related LinksN/A